Literature DB >> 20499219

Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.

Satishkumar P Jain1, Dharmini C Mehta, Sejal P Shah, Pirthi Pal Singh, Purnima D Amin.   

Abstract

Microcrystalline cellulose (MCC) is well established as an extrusion spheronisation aid for the preparation of pellets. Crospovidone (Polyplasdone XL-10) is compared with microcrystalline cellulose for the preparation of melt-in-mouth pellets. Taste-masked fexofenadine hydrochloride was incorporated in the melt-in-mouth formulation. Crospovidone was found to be well suited as extrusion-spheronisation aid for the preparation of melt-in-mouth pellets. The great advantage of crospovidone is, however, the disintegrating properties of the pellets after only a short time of exposure to liquid. Crospovidone was successfully employed as an extrusion-spheronisation aid to produce melt-in-mouth pellets obviating the need of a traditional extrusion-spheronisation aid, MCC. Dual properties of Crospovidone were explored viz. as an extrusion-spheronisation aid and a disintegrant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20499219      PMCID: PMC2902318          DOI: 10.1208/s12249-010-9443-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  31 in total

1.  Fast dispersible ibuprofen tablets.

Authors:  Simone Schiermeier; Peter Christian Schmidt
Journal:  Eur J Pharm Sci       Date:  2002-04       Impact factor: 4.384

2.  Release performance of a poorly soluble drug from a novel, Eudragit-based multi-unit erosion matrix.

Authors:  K A Mehta; M S Kislalioglu; W Phuapradit; A W Malick; N H Shah
Journal:  Int J Pharm       Date:  2001-02-01       Impact factor: 5.875

3.  Production of chitosan pellets by extrusion/spheronization.

Authors:  H Steckel; F Mindermann-Nogly
Journal:  Eur J Pharm Biopharm       Date:  2004-01       Impact factor: 5.571

4.  Extrusion/spheronization of pectin-based formulations. I. Screening of important factors.

Authors:  T Tho; P Kleinebudde; S A Sande
Journal:  AAPS PharmSciTech       Date:  2001-12-01       Impact factor: 3.246

5.  Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables.

Authors:  H Santos; F Veiga; M Pina; F Podczeck; J Sousa
Journal:  Int J Pharm       Date:  2002-10-10       Impact factor: 5.875

6.  Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose.

Authors:  A W Basit; J M Newton; L F Lacey
Journal:  Pharm Dev Technol       Date:  1999       Impact factor: 3.133

7.  Characterization and taste-masking evaluation of acetaminophen granules: comparison between different preparation methods in a high-shear mixer.

Authors:  Beatrice Albertini; Cristina Cavallari; Nadia Passerini; Dario Voinovich; Marisa L González-Rodríguez; Lorenzo Magarotto; Lorenzo Rodriguez
Journal:  Eur J Pharm Sci       Date:  2004-02       Impact factor: 4.384

8.  Disintegrating pellets from a water-insoluble pectin derivative produced by extrusion/spheronisation.

Authors:  Ingunn Tho; Sverre Arne Sande; Peter Kleinebudde
Journal:  Eur J Pharm Biopharm       Date:  2003-11       Impact factor: 5.571

9.  Pectinic acid, a novel excipient for production of pellets by extrusion/spheronisation: preliminary studies.

Authors:  Ingunn Tho; Sverre Arne Sande; Peter Kleinebudde
Journal:  Eur J Pharm Biopharm       Date:  2002-07       Impact factor: 5.571

10.  Effect of drying on extruded pellets based on kappa-carrageenan.

Authors:  Markus Thommes; Wolfgang Blaschek; Peter Kleinebudde
Journal:  Eur J Pharm Sci       Date:  2007-03-06       Impact factor: 4.384

View more
  2 in total

1.  A Quality by Experimental Design Approach to Assess the Effect of Formulation and Process Variables on the Extrusion and Spheronization of Drug-Loaded Pellets Containing Polyplasdone® XL-10.

Authors:  Kalyan K Saripella; Nikhil C Loka; Rama Mallipeddi; Anuja M Rane; Steven H Neau
Journal:  AAPS PharmSciTech       Date:  2015-07-14       Impact factor: 3.246

2.  Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study.

Authors:  Manu Sharma; Ranju Soni
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.